Fred T. Bizzarro

894 total citations
9 papers, 615 citations indexed

About

Fred T. Bizzarro is a scholar working on Molecular Biology, Organic Chemistry and Surgery. According to data from OpenAlex, Fred T. Bizzarro has authored 9 papers receiving a total of 615 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Molecular Biology, 2 papers in Organic Chemistry and 2 papers in Surgery. Recurrent topics in Fred T. Bizzarro's work include Pancreatic function and diabetes (2 papers), Metabolism, Diabetes, and Cancer (2 papers) and Amino Acid Enzymes and Metabolism (1 paper). Fred T. Bizzarro is often cited by papers focused on Pancreatic function and diabetes (2 papers), Metabolism, Diabetes, and Cancer (2 papers) and Amino Acid Enzymes and Metabolism (1 paper). Fred T. Bizzarro collaborates with scholars based in United States and Switzerland. Fred T. Bizzarro's co-authors include J. P. TENGI, Mark Dvorozniak, Joseph F. Grippo, Ramakanth Sarabu, Robert F. Kester, Paige E. Mahaney, Wendy L. Corbett, Kevin R. Guertin, Cheryl Spence and Nancy-Ellen Haynes and has published in prestigious journals such as Science, Journal of the American Chemical Society and Journal of Medicinal Chemistry.

In The Last Decade

Fred T. Bizzarro

9 papers receiving 595 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Fred T. Bizzarro United States 8 373 335 182 160 63 9 615
Lida Qi United States 10 403 1.1× 335 1.0× 183 1.0× 121 0.8× 64 1.0× 15 656
Wendy L. Corbett United States 9 433 1.2× 373 1.1× 204 1.1× 363 2.3× 67 1.1× 13 844
Nancy-Ellen Haynes United States 6 410 1.1× 353 1.1× 277 1.5× 84 0.5× 79 1.3× 7 697
Tsuneo Yasuma Japan 12 511 1.4× 266 0.8× 361 2.0× 153 1.0× 31 0.5× 18 760
Paige E. Mahaney United States 15 487 1.3× 434 1.3× 203 1.1× 320 2.0× 66 1.0× 27 1.0k
Tomoyuki Odani Japan 11 347 0.9× 162 0.5× 215 1.2× 90 0.6× 23 0.4× 14 542
Alan D. Adams United States 14 483 1.3× 262 0.8× 102 0.6× 104 0.7× 119 1.9× 16 766
Xian‐Yun Jiao United States 14 369 1.0× 129 0.4× 106 0.6× 301 1.9× 44 0.7× 22 704
R Saperstein United States 9 519 1.4× 74 0.2× 103 0.6× 63 0.4× 210 3.3× 17 703
Donald F. Diedrich United States 14 376 1.0× 114 0.3× 75 0.4× 33 0.2× 109 1.7× 33 590

Countries citing papers authored by Fred T. Bizzarro

Since Specialization
Citations

This map shows the geographic impact of Fred T. Bizzarro's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fred T. Bizzarro with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fred T. Bizzarro more than expected).

Fields of papers citing papers by Fred T. Bizzarro

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Fred T. Bizzarro. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fred T. Bizzarro. The network helps show where Fred T. Bizzarro may publish in the future.

Co-authorship network of co-authors of Fred T. Bizzarro

This figure shows the co-authorship network connecting the top 25 collaborators of Fred T. Bizzarro. A scholar is included among the top collaborators of Fred T. Bizzarro based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Fred T. Bizzarro. Fred T. Bizzarro is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

9 of 9 papers shown
1.
Haynes, Nancy-Ellen, Wendy L. Corbett, Fred T. Bizzarro, et al.. (2010). Discovery, Structure−Activity Relationships, Pharmacokinetics, and Efficacy of Glucokinase Activator (2R)-3-Cyclopentyl-2-(4-methanesulfonylphenyl)-N-thiazol-2-yl-propionamide (RO0281675). Journal of Medicinal Chemistry. 53(9). 3618–3625. 36 indexed citations
2.
Grimsby, Joseph, Ramakanth Sarabu, Wendy L. Corbett, et al.. (2003). Allosteric Activators of Glucokinase: Potential Role in Diabetes Therapy. Science. 301(5631). 370–373. 408 indexed citations
3.
Kuehne, Martin E., William G. Bornmann, István E. Markó, et al.. (2003). Syntheses and biological evaluation of vinblastine congeners. Organic & Biomolecular Chemistry. 1(12). 2120–2136. 40 indexed citations
4.
Cohen, Noal, Fred T. Bizzarro, George W. Holland, et al.. (1994). Benzenepropanoic acids containing chromanone or naphthalenone moieties are potent and orally active leukotriene B4 antagonists. Bioorganic & Medicinal Chemistry Letters. 4(24). 2883–2888. 7 indexed citations
5.
Bizzarro, Fred T., et al.. (1991). Simple Stereospecific Syntheses of (R)-2-Fluorohexanoic Acid Ethyl Ester. Synthetic Communications. 21(21). 2165–2170. 17 indexed citations
6.
Coffen, David L., et al.. (1984). 2-Benzazepines. 8. Zerovalent nickel mediated biaryl synthesis of an anxiolytic pyrimido[5,4-d][2]benzazepine. The Journal of Organic Chemistry. 49(2). 296–300. 22 indexed citations
7.
Vasilevskis, J., et al.. (1978). Synthesis of d-biotin via dehydrobiotin. Journal of the American Chemical Society. 100(23). 7423–7424. 15 indexed citations
8.
Scott, John W., David R. Parrish, & Fred T. Bizzarro. (1977). A RAPID AND MILD PROCESS FOR THE OXIDATION OF 2,3-DICHLORO-5,6-DICYANOBENZOQUINONE (DDQ) FROM 2,3-DICHLORO-5,6-DICYANOHYDROQUINONE (DDHQ). Organic Preparations and Procedures International. 9(2). 91–94. 9 indexed citations
9.
Scott, John W., Fred T. Bizzarro, David R. Parrish, & G. Saucy. (1976). Syntheses of (2R, 4′R, 8′R)‐α‐Tocopherol and (2R, 3′E, 7′E)‐α‐Tocotrienol. Helvetica Chimica Acta. 59(1). 290–306. 61 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026